Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech GlobeNewswire August 15, 2025 – Live video webcast on Thursday, August 21st at 2:20 PM ET THE WOODLANDS, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing […]

Green Box to Open 2026 Artist Residency Applications on September 2

Green Box to Open 2026 Artist Residency Applications on September 2 Renowned arts organization invites national and international creators to Colorado's Front Range for immersive residency experiences GlobeNewswire August 15, 2025 Green Mountain Falls, Colorado, Aug. 15, 2025 (GLOBE NEWSWIRE) — Nestled beneath America's Mountain, Pikes Peak, Green Box invites artists from around the world

Fortinet to Participate in Fireside Chat Hosted by Goldman Sachs

Fortinet to Participate in Fireside Chat Hosted by Goldman Sachs GlobeNewswire August 15, 2025 SUNNYVALE, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) — News SummaryFortinet(R) (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today announced that Ken Xie, Founder, Chairman and Chief Executive Officer, and Christiane Ohlgart, Chief Financial Officer, will

BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor

BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor GlobeNewswire August 15, 2025 First-in-human study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102, an orally available small molecule with potential best-in-class profile Initial development planned in obesity; BGE-102 demonstrated robust weight loss in preclinical models, both

AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update

AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire August 15, 2025 Continued progress across pipeline programs with focus on pancreatic cancer Mid-year report of Ampligen(R) (rintatolimod) in combination with AstraZeneca's Imfinzi(R) (durvalumab) for the treatment of pancreatic cancer demonstrates promising signs of both no significant toxicity and superior PFS and

Workhorse Group and Motiv Electric Trucks Executed Definitive Agreement to Combine, Creating a Leading Medium-Duty Electric Truck OEM in North America

Workhorse Group and Motiv Electric Trucks Executed Definitive Agreement to Combine, Creating a Leading Medium-Duty Electric Truck OEM in North America GlobeNewswire August 15, 2025 Joins Workhorse's proven vehicles, manufacturing capabilities and national dealer network with Motiv's diverse product portfolio and top fleet relationships Positions combined company to create value by offering broader portfolio of

Cingulate Provides Management Team Update

Cingulate Provides Management Team Update GlobeNewswire August 15, 2025 Jennifer Callahan, Chief Financial Officer, appointed Interim CEO Board member, Jay Roberts appointed Executive Chairman KANSAS CITY, Kan., Aug. 15, 2025 (GLOBE NEWSWIRE) — (NASDAQ: CING) The Board of Directors of Cingulate Inc. (“Cingulate”) announced that it has placed Chairman and Chief Executive Officer, Shane J.

HeartSciences Announces Conference Participation and Investor Webinar

HeartSciences Announces Conference Participation and Investor Webinar Virtual Events Include Investor Webinar and Presentation at Emerging Growth Conference 85 GlobeNewswire August 15, 2025 Southlake, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) — HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (“AI”)-powered medical technology company transforming ECGs/EKGs to enable earlier detection of heart

Faruqi & Faruqi Reminds RxSight Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 – RXST

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In RxSight To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in RxSight between November 7, 2024 and July 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh

ASP Isotopes Inc. and its Subsidiary, Quantum Leap Energy LLC, enter into a Memorandum of Understanding with Fermi America Regarding a Joint Venture to Collaborate on the Research, Development and Construction of an Advanced Nuclear Fuel Research and Production Facility at the Planned 11GW HyperGrid Campus in Carson County, Texas

(NASDAQ:ASPI), – Fermi America is a private U.S. developer of the planned HyperGrid campus near Amarillo, Texas, which is leased from Texas Tech University and is expected to be the world's largest hybrid energy and data infrastructure campus providing 11GW of power. – Fermi America was co-founded by Rick Perry, the former U.S. Energy Secretary

Scroll to Top